We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current REGN34 market cap is 7.57B. The company's latest EPS is USD 40.8302 and P/E is 16.81.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.43B | 3.15B | 3.55B | 3.72B | 3.79B |
| Operating Income | 972.9M | 751.4M | 1.07B | 1.18B | 990.2M |
| Net Income | 1.16B | 722M | 1.43B | 1.34B | 917.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.78B | 16.12B | 12.26B | 13.12B | 14.2B |
| Operating Income | 3.58B | 8.95B | 4.74B | 4.05B | 3.99B |
| Net Income | 3.51B | 8.08B | 4.34B | 3.95B | 4.41B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33.08B | 34.37B | 36.09B | 37.44B | 37.76B |
| Total Liabilities | 7.11B | 7.38B | 7.88B | 8.12B | 8.41B |
| Total Equity | 25.97B | 26.99B | 28.21B | 29.33B | 29.35B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.16B | 25.43B | 29.21B | 33.08B | 37.76B |
| Total Liabilities | 6.14B | 6.67B | 6.55B | 7.11B | 8.41B |
| Total Equity | 11.03B | 18.77B | 22.66B | 25.97B | 29.35B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.59B | 1.51B | 1.87B | 3.16B | 4.42B |
| Investing | -3.19B | -1.69B | -2.24B | -2.82B | -2.47B |
| Financing | -1.79B | 47.1M | -431M | -1.07B | -2.2B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.62B | 7.08B | 5.01B | 4.59B | 4.42B |
| Investing | -70.6M | -5.38B | -3.78B | -3.19B | -2.47B |
| Financing | -1.97B | -1.01B | -1.01B | -1.79B | -2.2B |
| Market Cap | 7.57B |
| Price to Earnings Ratio | 16.81 |
| Price to Sales Ratio | 5.22 |
| Price to Cash Ratio | 29.81 |
| Price to Book Ratio | 2.53 |
| Dividend Yield | 0.08% |
| Shares Outstanding | 108.07M |
| Average Volume (1 week) | 31 |
| Average Volume (1 Month) | 545 |
| 52 Week Change | -13.24% |
| 52 Week High | 111.72 |
| 52 Week Low | 60.11 |
| Spread (Intraday) | 3.7 (5.14%) |
| Company Name | Regeneron Pharmaceuticals Inc |
| Address |
28 liberty street new york, new york 10005 |
| Website | https://www.regeneron.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
